Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Extending Ketamine's Effects in Obsessive-Compulsive Disorder (OCD) With Exposure and Response Prevention (EX/RP)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02062658

Organisation Name: New York State Psychiatric Institute

Overal Status: Completed

Start Date: December 2013

Last Update: December 29, 2016

Lead Sponsor: New York State Psychiatric Institute

Brief Summary: This study investigates if a single dose of IV Ketamine can rapidly improve Obsessive-Compulsive Disorder (OCD) symptoms and whether these effect can be maintained with a condensed course of a type of Cognitive Behavioral Therapy called Exposure and Response Prevention (EX/RP). You will be compensated for your time and travel. Participants must be between the ages of 18-55.

Conditions:
  • Obsessive-Compulsive Disorder


Total execution time in seconds: 0.15229988098145